1- Al-Malki, E. S. and N. Abdelsater. 2020. In vitro Scolicidal effects of Androctonus crassicauda (Olivier, 1807) venom against the protoscolices of Echinococcus granulosus. Saudi Journal of Biological Sciences 27: 1760-1765.
2- Amani, J., K. A Barjini, M. M Moghaddam and A. Asadi. 2015. In vitro synergistic effect of the CM11 antimicrobial peptide in combination with common antibiotics against clinical isolates of six species of multidrug-resistant pathogenic bacteria. Protein and peptide letters 22: 940-951.
3- Azad, M. B., A. M. Abou-Setta, B. F. Chauhan, R. Rabbani, J. Lys, L. Copstein, A. Mann, M. M. Jeyaraman, A. E. Reid and M. Fiander. 2017. Nonnutritive sweeteners and cardiometabolic health: a systematic review and meta-analysis of randomized controlled trials and prospective cohort studies. Cmaj 189: E929-E939.
4- Cobb, S. L. and P. W. Denny. 2010. Antimicrobial peptides for leishmaniasis. Current opinion in investigational drugs 11: 868-875.
5- Dey, A. R., N. Begum, M. A. Alim and M. Z. Alam. Multiple anthelmintic resistance in gastrointestinal nematodes of small ruminants in Bangladesh. Parasitology international 77: 102105.
6- Ebrahimi, R., M. Yakhchali and H. Malekinejad. 2020. Anthelmintic resistance to Albendazole and Fenbendazole in gastrointestinal nematodes of sheep in Saghez Municipality, Iran. Journal of Veterinary Research 75(1):1-7.
7- Ebrahimzade, E., M. Mohebali, P. Shayan, S. Mohammadi-Yeganeh, M. M. Moghaddam, S. Elikaee, B. Akhoundi and M. K. Sharifi-Yazdi. 2019. Investigation of the antimicrobial activity of a short cationic peptide against promastigote and amastigote forms of Leishmania major (MHRO/IR/75/ER): An in vitro study. Experimental parasitology 196: 48-54.
8- Enkai, S., H. Kouguchi, D. K. Inaoka, T. Irie, K. Yagi and K. Kita. 2021. In vivo efficacy of combination therapy with albendazole and atovaquone against primary hydatid cysts in mice. European Journal of Clinical Microbiology & Infectious Diseases 40: 1815-1820.
9- Ferre, R., E. Badosa, L. Feliu, M. Planas, E. Montesinos and E. Bardají. 2006. Inhibition of plant-pathogenic bacteria by short synthetic cecropin A-melittin hybrid peptides. Applied and Environmental Microbiology 72: 3302-3308.
10- HashemiTabar , Razmi.GR and Maleki.M. 2009. In vivo effect of albendazole and mebendazole on hydatid cyst of mice. Archives of Razi Institute 64: 45-50.
11- Jafari. H, Nemati. M, Haddad Molayan, Khaleghi. P, Rostamkolaie.L and H. Nejat.H. 2019. Scolicidal activity of Mesobuthus eupeus venom against the protoscolices of Echinococcus granulosus. Archives of Razi Institute 74: 183-189.
12- Landa, A., L. Jiménez, K. Willms, L. F. Jiménez-García, R. Lara-Martínez, L. Robert, O. Cirioni, W. Barańska–Rybak and W. Kamysz. 2009. Antimicrobial peptides (Temporin A and Iseganan IB-367): Effect on the cysticerci of Taenia crassiceps. Molecular and biochemical parasitology 164: 126-130.
13- Maggiore, M. A., A. A. Albanese, L. B. Gende, M. J. Eguaras, G. M. Denegri and M. C. Elissondo. 2012. Anthelmintic effect of Mentha spp. essential oils on Echinococcus granulosus protoscoleces and metacestodes. Parasitology research 110: 1103-1112.
14- Mahmoudvand, H., A. Asadi, M. F. Harandi, F. Sharififar, S. Jahanbakhsh and E. S. Dezaki. 2014. In vitro lethal effects of various extracts of Nigella sativa seed on hydatid cyst protoscoleces. Iranian journal of basic medical sciences 17: 1001.
15- Moazeni, M., S. Larki, M. J. Saharkhiz, A. Oryan, M. Ansary Lari and A. Mootabi Alavi. 2014. In vivo study of the efficacy of the aromatic water of Zataria multiflora on hydatid cysts. Antimicrobial agents and chemotherapy 58: 6003-6008.
16- Moazeni, M. and A. Nazer. 2010. In vitro effectiveness of garlic (Allium sativum) extract on scolices of hydatid cyst. World journal of surgery 34: 2677-2681.
17- Moazeni, M., M. J. Saharkhiz and A. A. Hosseini. 2012. In vitro lethal effect of ajowan (Trachyspermum ammi L.) essential oil on hydatid cyst protoscoleces. Veterinary parasitology 187: 203-208.
18- Moghaddam, M. M., F. Abolhassani, H. Babavalian, R. Mirnejad, K. Azizi Barjini and J. Amani. 2012. Comparison of in vitro antibacterial activities of two cationic peptides CM15 and CM11 against five pathogenic bacteria: Pseudomonas aeruginosa, Staphylococcus aureus, Vibrio cholerae, Acinetobacter baumannii, and Escherichia coli. Probiotics and antimicrobial proteins 4: 133-139.
19- Morré, D. J., E. Sun, C. Geilen, L.-Y. Wu, R. De Cabo, K. Krasagakis, C. Orfanos and D. Morre. 1996. Capsaicin inhibits plasma membrane NADH oxidase and growth of human and mouse melanoma lines. European Journal of Cancer 32: 1995-2003.
20- Namaei, M. H., R. Solgi and A. Tavakoli Kareshk. 2022. Prosopis farcta Extract Potentiates the Scolicidal Activity Against Protoscolices of Hydatid Cysts. Proceedings of the National Academy of Sciences, India Section B: Biological Sciences: 1-6.
21- Rokni, M. 2009. Echinococcosis/hydatidosis in Iran. Iranian J Parasitol 4: 1-16.
22- Rouhani, S., N. Salehi, M. Kamalinejad and F. Zayeri. 2013. Efficacy of Berberis vulgaris aqueous extract on viability of Echinococcus granulosus protoscolices. Journal of Investigative Surgery 26: 347-351.
23- Sayek, I., M. B. Tirnaksiz and R. Dogan. 2004. Cystic hydatid disease: current trends in diagnosis and management. Surgery today 34: 987-996.
24- Sazmand, A., G. Alipoor, S. Zafari, S. M. Zolhavarieh, A. D. Alanazi and N. D. Sargison. 2020. Assessment of knowledge, attitudes and practices relating to parasitic diseases and anthelmintic resistance among livestock farmers in Hamedan, Iran. Frontiers in veterinary science 7: 584323.
25- Slocinska, M., P. Marciniak and G. Rosinski. 2008. Insects antiviral and anticancer peptides: new leads for the future Protein and peptide letters 15: 578-585.
26- Tamang, D. G. and M. H. Saier Jr. 2006. The cecropin superfamily of toxic peptides. Microbial Physiology 11: 94-103.
27- Thevissen, K., H.-H. Kristensen, B. P. Thomma, B. P. Cammue and I. E. Francois. 2007. Therapeutic potential of antifungal plant and insect defensins. Drug discovery today 12: 966-971.
28- Zhang, L. and T. J. Falla. 2009. Host defense peptides for use as potential therapeutics. Current opinion in investigational drugs (London, England: 2000) 10: 164-171.